Table 1 Association of the frequency of Foxp3+ cells and S1P1 expression in tumor tissues with the clinical parameters of 116 patients with bladder carcinoma in 2003–2004
Clinicopathological parameter | High level of Foxp3+ (%) | P-value | High level of S1P1+ (%) | P-value |
|---|---|---|---|---|
Age | ||||
<60 y | 34 (54.0) | 0.445 | 32 (50.8) | 0.568 |
≥60 y | 27 (50.9) | 27 (50.9) | ||
Gender | ||||
Female | 50 (53.8) | 0.390 | 47(50.5) | 0.537 |
Male | 11 (47.8) | 12 (52.2) | ||
T status | ||||
NMI | 23 (39.0) | 0.002* | 23 (39.0) | 0.008* |
MI | 38 (66.7) | 36 (63.2) | ||
N status | ||||
0 | 56 (53.9) | 0.310 | 51 (49.0) | 0.198 |
1–3 | 5 (41.7) | 8 (66.7) | ||
M status | ||||
0 | 57 (53.3) | 0.434 | 55 (51.4) | 0.478 |
1–2 | 4 (44.4) | 4 (44.4) | ||
Grade | ||||
G1 | 24 (51.1) | 0.467 | 18 (38.3) | 0.020* |
G2–G3 | 37 (53.6) | 41 (59.4) | ||
Multiplicity | ||||
Unifocal | 59 (54.6) | 0.105 | 56 (51.9) | 0.339 |
Multifocal | 2 (25.0) | 3 (37.5) | ||
Treatment model | ||||
TURBT | 39 (53.4) | 0.482 | 35 (47.9) | 0.266 |
RC | 22 (51.2) | 24 (55.8) | ||
